Related Experiment Video
Updated: May 15, 2026

08:54
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
Four-dimensional dose evaluation using deformable image registration in radiotherapy for liver cancer
Sang Hoon Jung1, Sang Min Yoon, Sung Ho Park
1Department of Radiation Oncology, University of Ulsan College of Medicine, Seoul, South Korea.
Medical Physics
|January 10, 2013
Summary
Four-dimensional (4D) dose calculations using deformable image registration (DIR) in free-breathing radiotherapy showed no significant impact on target coverage. However, motion significantly altered dosimetric parameters for organs at risk, impacting treatment planning.
Area of Science:
- Radiation Oncology
- Medical Physics
- Radiotherapy Planning
Background:
- Respiratory motion introduces uncertainties in dose delivery during radiotherapy.
- Accurate dose assessment requires accounting for organ movement during treatment.
- Four-dimensional computed tomography (4DCT) enables motion-aware radiotherapy planning.
Purpose of the Study:
- To evaluate the dosimetric impact of respiratory motion on target volumes and critical organs.
- To assess the accuracy of four-dimensional (4D) dose calculations using deformable image registration (DIR).
- To compare 4D dose distributions with conventional 3D dose calculations in free-breathing radiotherapy.
Main Methods:
- Acquired 4DCT images for 11 liver cancer patients.
- Performed 3D dose planning and calculation based on end-exhalation phase images.
- Calculated 4D dose using DIR of all 4DCT phases.
- Compared dosimetric parameters between 3D and 4D dose calculations.
Main Results:
- No significant changes in dosimetric parameters for the gross tumor volume.
- Increased mean dose and generalized equivalent uniform dose (gEUD) for the liver.
- Decreased D(max) and gEUD for duodenum, stomach, and both kidneys.
- Reduced normal tissue complication probability (NTCP) for duodenum and stomach.
Conclusions:
- 4D dose calculation accounting for respiratory motion reveals no significant difference in target coverage.
- Respiratory motion can significantly alter physical and biological dosimetric parameters for normal organs.
- Motion-aware dose assessment is crucial for optimizing radiotherapy planning and reducing toxicity.

